Journal article
Should the Window for Intravenous Administration of Tissue Plasminogen Activator in the Treatment of Acute Ischemic Stroke be Extended to 4.5 Hours?
Authors
Patel T; Loewen PS
Journal
The Canadian Journal of Hospital Pharmacy, Vol. 62, No. 3, pp. 248–251
Publisher
Canadian Society of Healthcare-Systems Pharmacy
Publication Date
January 1, 2009
DOI
10.4212/cjhp.v62i3.798
ISSN
0008-4123